tiprankstipranks
Trending News
More News >
USANA Health (USNA)
NYSE:USNA
US Market

USANA Health (USNA) Ratios

Compare
176 Followers

USANA Health Ratios

USNA's free cash flow for Q4 2025 was $0.89. For the 2025 fiscal year, USNA's free cash flow was decreased by $ and operating cash flow was $0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.24 2.24 2.00 3.52 2.65
Quick Ratio
1.45 1.45 1.50 3.00 2.18
Cash Ratio
1.23 1.23 1.30 2.78 2.01
Solvency Ratio
0.32 0.32 0.40 0.62 0.56
Operating Cash Flow Ratio
0.17 0.17 0.44 0.59 0.72
Short-Term Operating Cash Flow Coverage
1.60 1.60 2.65 89.87 15.08
Net Current Asset Value
$ 131.76M$ 131.76M$ 117.33M$ 282.19M$ 219.15M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.02 0.05 0.02 0.02
Debt-to-Equity Ratio
0.03 0.03 0.07 0.03 0.03
Debt-to-Capital Ratio
0.03 0.03 0.07 0.03 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.39 1.39 1.41 1.27 1.37
Debt Service Coverage Ratio
4.38 4.08 2.77 80.58 12.84
Interest Coverage Ratio
60.41 60.41 236.03 355.23 560.49
Debt to Market Cap
0.04 0.04 0.03 <0.01 <0.01
Interest Debt Per Share
0.81 0.80 2.07 0.70 0.73
Net Debt to EBITDA
-1.52 -1.59 -1.44 -2.58 -2.11
Profitability Margins
Gross Profit Margin
78.29%78.29%79.43%79.44%79.24%
EBIT Margin
5.98%5.50%8.97%11.15%10.90%
EBITDA Margin
10.27%9.79%11.57%13.37%13.04%
Operating Profit Margin
5.50%5.50%7.76%10.11%10.78%
Pretax Profit Margin
4.49%4.49%8.94%11.12%10.88%
Net Profit Margin
1.16%1.16%4.92%6.93%6.94%
Continuous Operations Profit Margin
1.24%1.24%4.92%6.93%6.94%
Net Income Per EBT
25.91%25.91%55.05%62.26%63.85%
EBT Per EBIT
81.65%81.65%115.12%110.08%100.94%
Return on Assets (ROA)
1.45%1.45%5.62%10.08%11.63%
Return on Equity (ROE)
2.03%2.02%7.90%12.83%15.96%
Return on Capital Employed (ROCE)
8.28%8.28%10.90%18.11%23.77%
Return on Invested Capital (ROIC)
2.24%2.24%5.73%11.10%14.95%
Return on Tangible Assets
2.28%2.28%9.29%10.89%12.68%
Earnings Yield
3.42%2.98%6.18%6.18%6.77%
Efficiency Ratios
Receivables Turnover
0.00 0.00 103.92 127.90 138.44
Payables Turnover
11.63 11.63 14.67 18.81 18.76
Inventory Turnover
1.96 1.96 2.52 3.08 3.09
Fixed Asset Turnover
9.80 9.80 9.04 9.23 8.48
Asset Turnover
1.25 1.25 1.14 1.46 1.67
Working Capital Turnover Ratio
6.06 6.18 3.90 3.43 4.54
Cash Conversion Cycle
155.09 155.09 123.45 101.88 101.32
Days of Sales Outstanding
0.00 0.00 3.51 2.85 2.64
Days of Inventory Outstanding
186.47 186.47 144.83 118.43 118.14
Days of Payables Outstanding
31.37 31.37 24.89 19.41 19.46
Operating Cycle
186.47 186.47 148.34 121.29 120.77
Cash Flow Ratios
Operating Cash Flow Per Share
1.22 1.20 3.20 3.67 5.40
Free Cash Flow Per Share
0.47 0.46 2.67 2.92 4.86
CapEx Per Share
0.76 0.74 0.53 0.75 0.54
Free Cash Flow to Operating Cash Flow
0.38 0.38 0.83 0.79 0.90
Dividend Paid and CapEx Coverage Ratio
1.62 1.62 6.05 4.87 9.99
Capital Expenditure Coverage Ratio
1.62 1.62 6.05 4.87 9.99
Operating Cash Flow Coverage Ratio
1.60 1.60 1.56 5.35 7.54
Operating Cash Flow to Sales Ratio
0.02 0.02 0.07 0.08 0.10
Free Cash Flow Yield
2.71%2.36%7.48%5.44%9.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.07 33.56 16.19 16.18 14.77
Price-to-Sales (P/S) Ratio
0.34 0.39 0.80 1.12 1.03
Price-to-Book (P/B) Ratio
0.59 0.68 1.28 2.08 2.36
Price-to-Free Cash Flow (P/FCF) Ratio
36.64 42.35 13.36 18.38 10.95
Price-to-Operating Cash Flow Ratio
14.00 16.16 11.16 14.61 9.86
Price-to-Earnings Growth (PEG) Ratio
-0.78 -0.46 -0.48 -2.16 -0.39
Price-to-Fair Value
0.59 0.68 1.28 2.08 2.36
Enterprise Value Multiple
1.77 2.39 5.44 5.80 5.76
Enterprise Value
169.69M 216.70M 537.83M 714.59M 749.68M
EV to EBITDA
1.79 2.39 5.44 5.80 5.76
EV to Sales
0.18 0.23 0.63 0.78 0.75
EV to Free Cash Flow
19.90 25.42 10.56 12.73 8.02
EV to Operating Cash Flow
7.59 9.70 8.82 10.12 7.22
Tangible Book Value Per Share
17.22 16.97 15.23 23.39 19.98
Shareholders’ Equity Per Share
29.13 28.70 27.91 25.83 22.57
Tax and Other Ratios
Effective Tax Rate
0.72 0.72 0.45 0.38 0.36
Revenue Per Share
50.55 49.81 44.82 47.84 51.86
Net Income Per Share
0.59 0.58 2.20 3.31 3.60
Tax Burden
0.26 0.26 0.55 0.62 0.64
Interest Burden
0.75 0.82 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.01 0.01 0.01
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.01 0.02 0.02 0.01
Income Quality
1.95 2.08 1.45 1.11 1.50
Currency in USD